Physicians' Academy for Cardiovascular Education

Update on SGLT2 inhibition in T2DM: A closer look at EMPA-REG OUTCOME

Slides (presentation) - Aug. 23, 2016

Presentation prepared and held by David Fitchett, MD - University of Toronto, Canada at the Asian Interchange on Diabetes meeting 'Innovation in T2DM: How will novel interventions impact clinical care?' held on July 30-31, 2016 in Bangkok, Thailand.
 2.3 Update on SGLT2 inhibition for Bangkok.pdf (2,1MB)2.3 Update on SGLT2 inhibition for Bangkok.pdf (2,1MB)

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: